TAT and infection: Results from luciferase assay revealed significant reduction of luciferase activity in the cells, again verifying the effectiveness of Cas9 activation by Tat, which is produced upon infection by HIV-1JRFL or HIV-1SF162 in shutting down the integrated HIV-1 luciferase gene.